Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/26/2026 | Q4 | $3.2B | -- | -- | $1.13 | -- |
| 10/20/2025 | Q3 | $3.2B | $3.8B | $1.28 | $1.10 | $0.17 |
| 07/21/2025 | Q2 | $3.1B | $3.7B | $1.00 | $1.02 | -$0.02 |
| 04/21/2025 | Q1 | $3B | $3.5B | $1.04 | $0.99 | $0.06 |
| 01/27/2025 | Q4 | $3B | $3.7B | $1.44 | $0.95 | $0.48 |
| 10/21/2024 | Q3 | $2.9B | $3.4B | $0.91 | $0.92 | -$0.01 |
| 07/22/2024 | Q2 | $2.8B | $3.3B | $0.92 | $0.93 | -$0.00 |
| 04/23/2024 | Q1 | $2.8B | $3.3B | $1.09 | $0.95 | $0.14 |
| 01/24/2024 | Q4 | $2.7B | $3.2B | $0.98 | $0.92 | $0.06 |
| 10/23/2023 | Q3 | -- | $3B | $0.82 | -- | -- |
| 07/20/2023 | Q2 | -- | $3B | $0.87 | -- | -- |
| 04/20/2023 | Q1 | -- | $2.9B | $0.71 | -- | -- |
| 01/26/2023 | Q4 | -- | $3B | $0.91 | -- | -- |
| 10/24/2022 | Q3 | -- | $2.7B | $0.55 | -- | -- |
| 07/21/2022 | Q2 | -- | $2.5B | $0.43 | -- | -- |
| 04/25/2022 | Q1 | -- | $2.9B | $1.41 | -- | -- |
| 01/27/2022 | Q4 | -- | $2.6B | $0.70 | -- | -- |
| 10/21/2021 | Q3 | -- | $2.4B | $0.62 | -- | -- |
| 07/22/2021 | Q2 | -- | $2.3B | $0.56 | -- | -- |
| 04/20/2021 | Q1 | -- | $2.2B | $0.55 | -- | -- |
| 01/26/2021 | Q4 | -- | $2.3B | $0.74 | -- | -- |
| 10/20/2020 | Q3 | -- | $2B | $0.36 | -- | -- |
| 07/21/2020 | Q2 | -- | $1.9B | $0.17 | -- | -- |
| 04/21/2020 | Q1 | -- | $1.8B | -$0.01 | -- | -- |
| 01/28/2020 | Q4 | -- | $2B | $0.27 | -- | -- |
| 10/22/2019 | Q3 | -- | $2B | $0.38 | -- | -- |
| 07/23/2019 | Q2 | -- | $2B | $0.50 | -- | -- |
| 04/23/2019 | Q1 | -- | $1.9B | $0.42 | -- | -- |
| 01/29/2019 | Q4 | -- | $2B | $0.31 | -- | -- |
| 10/23/2018 | Q3 | -- | $1.9B | $0.37 | -- | -- |
| 07/24/2018 | Q2 | -- | $1.9B | $0.42 | -- | -- |
| 04/24/2018 | Q1 | -- | $1.9B | $0.38 | -- | -- |
| 01/30/2018 | Q4 | -- | $1.9B | $0.36 | -- | -- |
| 10/24/2017 | Q3 | -- | $2B | $0.37 | -- | -- |
| 07/25/2017 | Q2 | -- | $1.8B | $0.25 | -- | -- |
| 04/24/2017 | Q1 | -- | $1.9B | $0.28 | -- | -- |
| 01/31/2017 | Q4 | -- | $2B | $0.36 | -- | -- |
| 10/25/2016 | Q3 | -- | $2B | $0.51 | -- | -- |
| 07/25/2016 | Q2 | -- | $1.9B | $0.25 | -- | -- |
| 04/26/2016 | Q1 | -- | $1.8B | $0.28 | -- | -- |
| 02/02/2016 | Q4 | -- | $1.8B | $0.25 | -- | -- |
W.R. Berkley Corp. reported $3.8B worth of top line sales in its most recent quarter.
W.R. Berkley Corp. announced earnings per share of $1.28 which represents a beat of analyst forecast a $1.10 per share.
W.R. Berkley Corp. reported -- that represents -- per share over the last quarter.
W.R. Berkley Corp.'s earnings are forecast to decrease from $4.36 per share to $4.01 per share next year representing a decrease of -1.28%.
W.R. Berkley Corp.'s next earnings date is January 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.